Columbia scientists have developed a new computational framework that can support precision cancer treatment by matching individual tumors with the drugs most likely to kill them.
Kyle Allison, recipient of the NIH Director’s Early Independence Award, is exploring how to keep common bacterial infections from becoming chronic illnesses.
Using an innovative algorithm, CUMC researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
New technology allows scientists to dive into the inner world of cells in everything from cancers to mummies. Learn more at lab’s open house on July 10.
P&S systems biologists dive into huge databases of genomes, proteins, and metabolites to find new ways to target the world’s most deadly pathogens.
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.